Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why These Five Stocks Are on the Move Today

In a marked reversal, crude futures are off 1.4% today after a disappointing EIA report, while the broader indexes are each higher as traders await the ‘Brexit’ outcome tomorrow.

Among the stocks showing more volatility than the indexes are MBIA Inc. (NYSE:MBI), Emergent Biosolutions Inc (NYSE:EBS), Inovio Pharmaceuticals Inc (NASDAQ:INO), Fitbit Inc (NYSE:FIT), and Nymox Pharmaceutical Corporation (NASDAQ:NYMX). Let’s find out why these stocks are trending today and see how the smart money investors tracked by us are positioned towards them.

While there are many metrics that investors can assess in the investment process, the hedge fund sentiment is something that is often overlooked. However, hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor to beat the S&P 500 by around 95 basis points per month (see the details here).

FDA drug testing

MBIA Rises on Analyst Commentary

MBIA Inc. (NYSE:MBI) shares have inched up by over 1% after BTIG analyst Mark Palmer reiterated his ‘Buy’ rating on MBIA and raised his price target to $14 from $13 per share. Palmer thinks the recent breakdown in discussions between creditors and Puerto Rico isn’t necessarily a negative sign as the two parties could come back on the table again. If the parties reach an acceptable agreement, MBIA shares could benefit from the lower uncertainty. A total of 23 funds in our database had a bullish position in MBIA Inc. (NYSE:MBI) at the end of March, unchanged from the previous quarter.

Follow Mbia Inc (NYSE:MBI)
Trade (NYSE:MBI) Now!

Emergent Declines on Solicitation Notices

Emergent Biosolutions Inc (NYSE:EBS) is 20% lower after the U.S. government issued solicitation notices to procure up to 56.4 million doses of anthrax vaccines. The notices include the procurement of 29.4 million doses of BioThrax and 27 million dose regimens of a next generation anthrax vaccine. Although Emergent intends to respond to both solicitations to meet the government’s timeline for completing the BioThrax procurement contract award in September and timely completion of a next generation anthrax vaccine advanced development contract award, traders were evidently expecting the government to procure more vaccines. The number of funds tracked by us with holdings in Emergent Biosolutions Inc (NYSE:EBS) rose by one quarter-over-quarter to 17 at the end of March.

Follow Emergent Biosolutions Inc. (NYSE:EBS)
Trade (NYSE:EBS) Now!

On the next page, we examine Inovio Pharmaceuticals, Fitbit, and Nymox Pharmaceutical Corporation.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.